| AstraZeneca AG - Imjudo 25 mg/1,25 ml, Konzentrat zur Herstellung einer Infusionslösung | | 68706 | | 01 | | Imjudo 25 mg/1,25 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FX20 | | Tremelimumab | | 13.09.2023 | | |
| | Composition | | tremelimumabum 25 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, dinatrii edetas corresp. natrium 0.012 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1.25 ml. | | Packungsbestandteile | | Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Tremelimumabum | 25mg / 1.25ml |
| | BAG: Active Agent | Dose |
|---|
| Tremelimumabum | 25 mg |
| | | | Inactive agents |
|---|
| Dinatrii Edetas | | Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 80 | | Trehalosum Dihydricum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 1410.24 | 1550.15 | A | SL | No |
|
|
